Previous Article | Next Article ![]()
Journal of Clinical Microbiology, January 2001, p. 139-145, Vol. 39, No. 1
Department of Biosciences, Microbiology,
University of Rostock, D-18055 Rostock, Germany
Received 20 July 2000/Returned for modification 23 August
2000/Accepted 10 October 2000
In recent years, the gram-negative bacterium Stenotrophomonas
maltophilia has become increasingly important in biotechnology and as a nosocomial pathogen, giving rise to a need for new information about its taxonomy and epidemiology. To determine intraspecies diversity and whether strains can be distinguished based on the sources
of their isolation, 50 S. maltophilia isolates from
clinical and environmental sources, including strains of
biotechnological interest, were investigated. The isolates were
characterized by in vitro antagonism against pathogenic fungi and the
production of antifungal metabolites and enzymes. Phenotypically the
strains showed variability that did not correlate significantly with
their sources of isolation. Clinical strains displayed remarkable
activity against the human pathogenic fungus Candida
albicans. Antifungal activity against plant pathogens was more
common and generally more severe from the environmental isolates,
although not exclusive to them. All isolates, clinical and
environmental, produced a range of antifungal metabolites including
antibiotics, siderophores, and the enzymes proteases and chitinases.
From 16S ribosomal DNA sequencing analysis, the isolates could be
separated into three clusters, two of which consisted of isolates
originating from the environment, especially rhizosphere isolates, and
one of which consisted of clinical and aquatic strains. In contrast to
the results of other recent investigations, these strains could be grouped based on their sources of isolation, with the exception of
three rhizosphere isolates. Because there was evidence of nucleotide signature positions within the sequences that are suitable for distinguishing among the clusters, the clusters could be defined as
different genomovars of S. maltophilia. Key sequences on
the 16S ribosomal DNA could be used to develop a diagnostic method that
differentiates these genomovars.
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.1.139-145.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Comparison of Antifungal Activities and 16S
Ribosomal DNA Sequences of Clinical and Environmental Isolates of
Stenotrophomonas maltophilia
*
Corresponding author. Mailing address: University of
Rostock, Department of Biosciences, Microbiology, Gertrudenstrasse 11A, D-18051 Rostock, Germany. Phone: 49-381-4942049. Fax: 49-381-4942244. E-mail: gabriele berg{at}biologie.uni-rostock.de.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»